EN IT

Reserved

Pfizer cede lo 0,6% e il flusso di denaro continua a risalire verso lo zero

·46 min read
EXECUTIVE VIEW

Pfizer analisi tecnica: doppio minimo per la seconda settimana di fila, volume in acquisto stabile al 70% e flusso di denaro in netto miglioramento. Il Segnale di Vendita, alla 10ª settimana di gestione, resta comunque in guadagno per lo short.

Reserved analysis Subscribe to read →
Reserved

Pfizer dips 0.6% as money flow keeps climbing back toward zero

·46 min read
EXECUTIVE VIEW

Pfizer weekly technical analysis and swing trading setup: a double bottom for the second week running, 70% buying volume, and money flow turning back toward zero — the Sell signal stays in profit in week 10.

Reserved analysis Subscribe to read →
Reserved

Pfizer: il ribasso rallenta, ma i tecnici non hanno ancora girato

·45 min read
EXECUTIVE VIEW

Pfizer è alla nona settimana di un segnale di vendita: la settimana si chiude quasi piatta dopo due cali consecutivi, con un doppio minimo e un rimbalzo del 6%, ma MACD e istogramma restano in peggioramento.

Reserved analysis Subscribe to read →
Reserved

Pfizer: the decline slows, but the technicals haven't turned yet

·45 min read
EXECUTIVE VIEW

Pfizer technical analysis, week 9 of a sell signal: the week closes nearly flat after two straight declines, with a double bottom and a 6% rebound, while MACD and histogram keep worsening.

Reserved analysis Subscribe to read →
Reserved

Pfizer, calo che tiene ma la pressione si attenua

·45 min read
EXECUTIVE VIEW

Alla 7ª settimana del segnale di vendita, Pfizer chiude ancora in calo. La struttura ribassista regge, ma la pressione si fa meno uniforme: da seguire con attenzione la settimana prossima.

Reserved analysis Subscribe to read →
Reserved

Pfizer: decline holds, but pressure is fading

·45 min read
EXECUTIVE VIEW

Pfizer sell signal at week 7 — weekly technical analysis shows the decline holds, but momentum is losing uniformity. Trade setup remains active; watch next week closely.

Reserved analysis Subscribe to read →
Share WhatsApp Telegram Gmail LinkedIn